Creso Pharma Ltd.
Creso Pharma Ltd. (ASX:CPH) (OTC:COPHF) (FRA:1X8) delivers pharmaceutical-grade Nutraceuticals and Medical Cannabis products with standardized dosing and formulations, and use proprietary innovative delivery technologies to enhance the bioavailability and absorption of the cannabinoid molecules.
From the outset, Creso’s goal has been to become the world’s most trusted supplier of cannabis and hemp derived products. The company’s experienced pharmaceutical leadership team have an unparalleled track record of success commercializing a wide range of pharmaceutical and therapeutic solutions.
Creso can deliver products with standardized dosing and formulations through the application of pharmaceutical rigour, Good Manufacturing Practices standards when appropriate and proprietary, innovative delivery technologies.
As a global company, Australia-based Creso Pharma is not limited by any single market. This enables Creso to offer a diverse portfolio of solutions to the widest possible population.
By partnering with leading global companies in critical areas of research and product development, manufacturing and distribution, Creso has been able to accelerate the development and distribution of approved products allowing for broad access by patients and consumers.